Corrections and Clarifications

Corrections and Clarifications

See allHide authors and affiliations

Science  10 Feb 1995:
Vol. 267, Issue 5199, pp. 777
DOI: 10.1126/science.267.5199.777

Abstract

In the report "GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle" by C. E. Henderson et al. (11 Nov., p. 1062), the seventh author's name should have been "Laura Simmons." The affiliation for authors H. S. Phillips, M. Armanini, and Arnon Rosenthal should have been "Department of Neuroscience, Genentech, South San Francisco, CA 94080-4990, USA." The affiliation for B. Moffet and R. A. Vandlen should have been "Department of Protein Chemistry, Genentech," and that for Laura Simmons should have been "Department of Cell Genetics, Genentech." Alun M. Davies is at the University of St. Andrews, St. Andrews, Fife, Scotland KY16 9AJ, United Kingdom, and Vassilis E. Koliatsos is in the Departments of Pathology, Neurology, and Neuroscience and the Neuropathology Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD 21208, USA. Beginning on line 19 of the first column on page 1064, the text should have read, "The average volume of the surviving motoneurons in the facial nuclei that received GDNF was 5186 ± 308 µ3, close to that in the control nuclei (6081 ± 105 µ3) (n = 3). In contrast, although BDNF and NT-⅘ both enhanced motoneuron survival to a similar degree as did GDNF (2, 3), neither of them prevented the axotomy-induced shrinkage of facial motoneurons. In BDNF and NT-⅘—treated nuclei, the volume of the surviving motoneurons was only 65.5 ± 4% and 63.3 ± 2.6% of the control nuclei, respectively (n = 3) (14)."